» Articles » PMID: 33277997

Ex Vivo Thyroid Fine Needle Aspirations As an Alternative for MALDI-MSI Proteomic Investigation: Intra-patient Comparison

Overview
Specialty Chemistry
Date 2020 Dec 5
PMID 33277997
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Fine needle aspiration (FNA) is the reference standard for the diagnosis of thyroid nodules. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) has been successfully used to discriminate the proteomic profiles of benign and malignant thyroid FNAs within the scope of providing support to pathologists for the classification of morphologically borderline cases. However, real FNAs provide a limited amount of material due to sample collection restrictions. Ex vivo FNAs could represent a valuable alternative, increasing sample size and the power of statistical conclusions. In this study, we compared the real and ex vivo MALDI-MSI proteomic profiles, extracted from thyrocyte containing regions of interest, of 13 patients in order to verify their similarity. Statistical analysis demonstrated the mass spectra similarity of the proteomic profiles by performing intra-patient comparison, using statistical similarity systems. In conclusion, these results show that post-surgical FNAs represent a possible alternative source of material for MALDI-MSI proteomic investigations in instances where pre-surgical samples are unavailable or the number of cells is scarce.

Citing Articles

Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI.

Piga I, Pagni F, Magni F, Smith A Methods Mol Biol. 2023; 2688:95-105.

PMID: 37410287 DOI: 10.1007/978-1-0716-3319-9_9.


Applications of spatially resolved omics in the field of endocrine tumors.

Hou Y, Gao Y, Guo S, Zhang Z, Chen R, Zhang X Front Endocrinol (Lausanne). 2023; 13:993081.

PMID: 36704039 PMC: 9873308. DOI: 10.3389/fendo.2022.993081.


Biological mass spectrometry enables spatiotemporal 'omics: From tissues to cells to organelles.

Pade L, Stepler K, Portero E, DeLaney K, Nemes P Mass Spectrom Rev. 2023; 43(1):106-138.

PMID: 36647247 PMC: 10668589. DOI: 10.1002/mas.21824.


Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies.

Capitoli G, Piga I, LImperio V, Clerici F, Leni D, Garancini M Int J Mol Sci. 2022; 23(8).

PMID: 35456973 PMC: 9028391. DOI: 10.3390/ijms23084156.

References
1.
Roskell D, Buley I . Fine needle aspiration cytology in cancer diagnosis. BMJ. 2004; 329(7460):244-5. PMC: 498011. DOI: 10.1136/bmj.329.7460.244. View

2.
DeHoog R, Zhang J, Alore E, Lin J, Yu W, Woody S . Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies. Proc Natl Acad Sci U S A. 2019; 116(43):21401-21408. PMC: 6815148. DOI: 10.1073/pnas.1911333116. View

3.
Capitoli G, Piga I, Galimberti S, Leni D, Pincelli A, Garancini M . MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules. Cancers (Basel). 2019; 11(9). PMC: 6769566. DOI: 10.3390/cancers11091377. View

3.
Pagni F, De Sio G, Garancini M, Scardilli M, Chinello C, Smith A . Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions. Proteomics. 2016; 16(11-12):1775-84. DOI: 10.1002/pmic.201500448. View

4.
Piga I, Capitoli G, Denti V, Tettamanti S, Smith A, Stella M . The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies. Anal Bioanal Chem. 2019; 411(20):5007-5012. DOI: 10.1007/s00216-019-01908-w. View